eIF4E inhibitors (Ribometrix)

N/A

Report date: 2025/06/11 10:41:59
NME

Base Information

Drug NameeIF4E inhibitors (Ribometrix)
Drug Alias NameRBX-4Ei05
ClassificationSmall molecules
Mechanisms of ActionEukaryotic translation initiation factor 4E inhibitors
TargetsEukaryotic translation initiation factor 4E
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRibometrix Inc
China Registration ClassN/A

Develop Information

Active CompaniesRibometrix Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A